Cubist Systematic Strategies’s iShares Biotechnology ETF IBB Stock Holding History

Cubist Systematic Strategies’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1M	Buy	+6,941	New	+$947K	﹤0.01%	1952

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cubist Systematic Strategies's IBB Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in iShares Biotechnology ETF (IBB) in Q3 2025: 6,941 shares worth $1M. The stake represents ﹤0.01% of the portfolio and ranks #1952 among its holdings.

803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

Cubist Systematic Strategies held 6,941 shares of iShares Biotechnology ETF worth $1M as of Q3 2025.
iShares Biotechnology ETF was a new Cubist Systematic Strategies position in Q3 2025.
iShares Biotechnology ETF made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1952 holding.
803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.